Valuation SMAIO

Stocks

Market Closed - Euronext Paris 11:55:00 2026-09-11 EDT			5-day change	1st Jan Change
7.400 ^EUR	0.00%		-3.39%	+18.40%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16.99	16.1	13.46	35.24	41.68	-	-
Change	-	-5.23%	-16.43%	161.89%	18.26%	-	-
Enterprise Value (EV) ¹	11.95	12.4	12.54	34.26	40.18	40.78	41.48
Change	-	3.81%	1.07%	173.25%	17.29%	1.49%	1.72%
P/E	-	15.2x	-5.73x	-15.2x	-19x	185x	34.4x
PBR	-	-	-	-	6.73x	6.73x	5.69x
PEG	-	-	0x	1.71x	3.9x	-2x	0x
Capitalization / Revenue	7.08x	2.99x	2.45x	3.83x	3.79x	2.61x	1.99x
EV / Revenue	4.98x	2.3x	2.28x	3.72x	3.65x	2.55x	1.98x
EV / EBITDA	-4.7x	6.02x	-7.16x	-28.1x	-36.5x	28.1x	16.3x
EV / EBIT	-2.99x	16.8x	-3.94x	-13x	-15.5x	-272x	51.9x
EV / FCF	2.34x	-9.16x	-4.19x	-26.5x	-14.6x	-32.6x	-415x
FCF Yield	42.7%	-10.9%	-23.8%	-3.78%	-6.84%	-3.07%	-0.24%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-	0.2024	-0.45	-0.41	-0.39	0.04	0.215
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	2.4	5.383	5.498	9.2	11	16	20.9
EBITDA ¹	-2.544	2.059	-1.751	-1.22	-1.1	1.45	2.55
EBIT ¹	-4	0.7368	-3.184	-2.628	-2.6	-0.15	0.8
Net income ¹	2.846	1.058	-2.349	-2.229	-2.25	0.25	1.2
Net Debt ¹	-5.044	-3.7	-0.921	-0.9873	-1.5	-0.9	-0.2
Reference price ²	3.250	3.080	2.580	6.250	7.400	7.400	7.400
Nbr of stocks (in thousands)	5,229	5,229	5,216	5,639	5,633	-	-
Announcement Date	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SMAIO	-18.97x	3.65x	-36.53x	-	48.38M
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	12.64x	5.98x	9.33x	2.51%	350.48B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%